1,581
Views
9
CrossRef citations to date
0
Altmetric
Research Article

Reversed lipid-based nanoparticles dispersed in oil for malignant tumor treatment via intratumoral injection

, , , , &
Pages 857-866 | Received 16 Mar 2017, Accepted 10 May 2017, Published online: 26 May 2017

References

  • A'hern RP, Smith IE, Ebbs SR. (1993). Chemotherapy and survival in advanced breast cancer: the inclusion of doxorubicin in Cooper type regimens. Br J Cancer 67:801–5.
  • Al-Abd AM, Hong KY, Song SC, Kuh HJ. (2010). Pharmacokinetics of doxorubicin after intratumoral injection using a thermosensitive hydrogel in tumor-bearing mice. J Control Release 142:101–7.
  • Bao AD, Phillips WT, Goins B, et al. (2006). Potential use of drug carried-liposomes for cancer therapy via direct intratumoral injection. Int J Pharm 316:162–9.
  • Cao Y, Zhang C, Shen W, et al. (2007). Poly(N-isopropylacrylamide)–chitosan as thermosensitive in situ gel-forming system for ocular drug delivery. J Control Release 120:186–94.
  • Carter SK, Soper WT. (1974). Integration of chemotherapy into combined modality treatment of solid tumors. 1. The Overall Strategy Cancer Treat Rev 1:1–13.
  • Chari RV. (2008). Targeted cancer therapy: conferring specificity to cytotoxic drugs. Acc Chem Res 41:98–107.
  • Chun C, Lee SM, Kim CW, et al. (2009). Doxorubicin-polyphosphazene conjugate hydrogels for locally controlled delivery of cancer therapeutics. Biomaterials 30:4752–62.
  • De Souza R, Zahedi P, Allen CJ, Piquette-Miller M. (2010). Polymeric drug delivery systems for localized cancer chemotherapy. Drug Deliv 17:365–75.
  • Ding Q, Li Z, Yang Y, et al. (2016). Preparation and therapeutic application of docetaxel-loaded poly(d,l-lactide) nanofibers in preventing breast cancer recurrence. Drug Deliv 23:2677–85.
  • Freitas S, Merkle HP, Gander B. (2005). Microencapsulation by solvent extraction/evaporation: reviewing the state of the art of microsphere preparation process technology. J Control Release 102:313–32.
  • Goins B, Phillips WT, Bao A. (2016). Strategies for improving the intratumoral distribution of liposomal drugs in cancer therapy. Expert Opin Drug Deliv 13:873–89.
  • Jenkins DE, Oei Y, Hornig YS. (2003). Bioluminescent imaging (BLI) to improve and refine traditional murine models of tumor growth and metastasis. Clin Exp Metastasis 20:733–44.
  • Jeong B, Kim SW, Bae YH. (2002). Thermosensitive sol-gel reversible hydrogels. Adv Drug Deliv Rev 54:37–51.
  • Lewis BJ. (1995). A Comparison of Lipiodol Chemoembolization and Conservative Treatment for Unresectable Hepatocellular Carcinoma. N Engl J Med 332:1256–61.
  • Llovet JM, Bruix J. (2003). Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology 37:429–42.
  • Moreno E, Schwartz J, Larraneta E, et al. (2014). Thermosensitive hydrogels of poly(methyl vinyl ether-co-maleic anhydride) - Pluronic (R) F127 copolymers for controlled protein release. Int J Pharm 459:1–9.
  • Nomura T, Koreeda N, Yamashita F, et al. (1998). Effect of particle size and charge on the disposition of lipid carriers after intratumoral injection into tissue-isolated tumors. Pharm Res 15:128–32.
  • Ruan G, Feng SS. (2003). Preparation and characterization of poly(lactic acid)-poly(ethylene glycol)-poly(lactic acid) (PLA-PEG-PLA) microspheres for controlled release of paclitaxel. Biomaterials 24:5037–44.
  • Wang X, Wang J, Wu W, Li H. (2016). Vaginal delivery of carboplatin-loaded thermosensitive hydrogel to prevent local cervical cancer recurrence in mice. Drug Deliv 23:3544–51.
  • Westphal M, Hilt DC, Bortey E, et al. (2003). A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma. Neuro Oncol 5:79–88.
  • Woo BH, Jiang G, Jo YW, Deluca PP. (2001). Preparation and characterization of a composite PLGA and poly(acryloyl hydroxyethyl starch) microsphere system for protein delivery. Pharm Res 18:1600–6.
  • Yu S, Zhang X, Tan G, et al. (2017). A novel pH-induced thermosensitive hydrogel composed of carboxymethyl chitosan and poloxamer cross-linked by glutaraldehyde for ophthalmic drug delivery. Carbohydr Polym 155:208–17.
  • Zhang G, Wang T, Gao L, Quan D. (2013). Oral delivery of oil-based formulation for a novel synthetic cationic peptide of GnRH (gonadotropin-releasing hormone) antagonist for prostate cancer treatment. Int J Pharm 450:138–44.
  • Zhang J, Wang X, Liu T, et al. (2016). Antitumor activity of electrospun polylactide nanofibers loaded with 5-fluorouracil and oxaliplatin against colorectal cancer. Drug Deliv 23:794–800.